[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346677-105":59,"doc-detail-346677-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","nanotechnology-enabled-diagnosis-and-treatment-of-hepatocellular-carcinoma-theranostics-combination-regimens-and-translation","Nanotechnology-Enabled Diagnosis and Treatment of Hepatocellular Carcinoma - Theranostics, Combination Regimens, and Translation","","This manuscript explores the innovative application of nanotechnology in the diagnosis and treatment of hepatocellular carcinoma (HCC), a leading cause of cancer-related mortality worldwide. Emphasizing the synergistic potential of nanotechnology, the review describes advanced nanomaterials and techniques, including targeted drug delivery, nanoparticle-based imaging, and multi-modal therapy, to improve precision and efficacy. It also covers early diagnosis via enhanced imaging and tumor-specific biomarkers, while discussing therapeutic advances such as targeted chemotherapeutic delivery, gene therapies, and immunotherapies to minimize side effects. Key challenges include bio-barrier penetration, biocompatibility, and high production costs, with future promise from combining nanotechnology with artificial intelligence and personalized medicine.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nanotechnology-enabled-diagnosis-and-treatment-of-hepatocellular-carcinoma-theranostics-combination-regimens-and-translation/346677/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nanotechnology-enabled-diagnosis-and-treatment-of-hepatocellular-carcinoma-theranostics-combination-regimens-and-translation/346677.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does nanotechnology improve early diagnosis of hepatocellular carcinoma (HCC)?","Question",{"text":112,"@type":113},"It enhances imaging capabilities and leverages tumor-specific biomarkers, enabling more accurate detection at early stages.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What nanotechnology-enabled therapeutic approaches are discussed for HCC?",{"text":117,"@type":113},"The review highlights targeted delivery of chemotherapeutic agents, gene therapies, and immunotherapies, aiming to improve patient outcomes while minimizing side effects.",{"name":119,"@type":110,"acceptedAnswer":120},"What major obstacles are identified for translating nanomedicine to clinical use?",{"text":121,"@type":113},"Key challenges include bio-barrier penetration, biocompatibility, and high production costs.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346677,1790180262,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":24,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","International Journal of Nanomedicine  \nOpen Access Full Text Article REVIEW  \nNanotechnology-Enabled Diagnosis and Treatment of Hepatocellular Carcinoma:  \nTheranostics, Combination Regimens, and Translation  \nSiyao Wang 1 , *, Yang Wu 1 , *, Miao Yuan 1 , *, Jing Zheng 1 , Chaoran Wang 1 , Jiarong Wang 1 , Yifan Zheng 1 , Qiaoyun Yang 1 , Mengran Xu 1 , Baiqi Wang 1 , 2  \n1Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, Tianjin, People’s Republic of China;  \n2National Demonstration Center for Experimental Preventive Medicine Education (Tianjin Medical University), Tianjin, People’s Republic of China *These authors contributed equally to this work  \nCorrespondence: Baiqi Wang, [Email wangbaiqi@tmu.edu.cn](Email wangbaiqi@tmu.edu.cn)  \n\n| Abstract: This manuscript explores the innovative application of nanotechnology in the diagnosis and treatment of hepatocellular carcinoma (HCC), a leading cause of cancer-related mortality worldwide. Emphasizing the synergistic potential of nanotechnology, the paper discusses advanced nanomaterials and techniques, such as targeted drug delivery systems, nanoparticle-based imaging, and multi-modal therapy, which enhance the precision and efficacy of HCC interventions. Nanotechnology offers significant improvements in early diagnosis through enhanced imaging capabilities and tumor-specific biomarkers, enabling more accurate detection of HCC at its early stages. Furthermore, it enables the development of novel therapeutic strategies, including the targeted delivery of chemotherapeutic agents, gene therapies, and immunotherapies, minimizing side effects and improving patient outcomes. The manuscript also highlights challenges such as bio-barrier penetration, biocompatibility, and the high production costs associated with nanomedicine. Despite these obstacles, the integration of nanotechnology with artificial intelligence and personalized medicine promises a transformative future for HCC treatment. This review underscores the pivotal role of nanotechnology in advancing both the diagnostic and therapeutic landscapes for HCC, offering a new frontier for improving survival rates and quality of life for patients. Keywords: hepatocellular carcinoma, diagnosis, treatment, nanotechnology, multimodality |\n| --- |\n| Introduction\u003Cbr>Global Epidemiology and Therapeutic Challenges of Hepatocellular Carcinoma (HCC) Epidemiological Analysis of HCC\u003Cbr>Primary liver cancer is a prevalent malignancy globally and is mainly composed of three pathological subtypes: HCC, intrahepatic cholangiocarcinoma (ICC), and combined hepatocellular-cholangiocarcinoma (CHC) . Among these, HCC is the most common, accounting for approximately 85% of primary liver cancer cases and ranking as the sixth most prevalent cancer worldwide.1,2 More than half of all primary liver cancer cases and deaths occur in regions such as Southeast Asia, Oceania, and sub-Saharan Africa, where incidence rates exceed 30 per 100,000 . In contrast, North America, Latin America, and Europe are considered low-incidence regions, with rates above 11 per 100,000 .3,4\u003Cbr>HCC is one of the most lethal malignancies, ranking as the third leading cause of cancer-related deaths worldwide. According to the GLOBOCAN database, liver cancer is responsible for approximately 830,000 deaths worldwide, with HCC accounting for about 75% of these cases.1,5 The overall five-year survival rate for HCC is approximately 18%, making it the third leading cause of cancer-related mortality worldwide.6–8 Over recent decades, the incidence of HCChas either declined or stabilized in some Asian countries, while the number of combined liver cancer and HCC cases in |\n\n[https://doi.org/10.2147/IJN.S581911](https://doi.org/10.2147/IJN.S581911)  \n[Received: 15 November 2025](Received: 15 November 2025)  \n[Accepted: 28 February 2026](Accepted: 28 February 2026)  \n[Published: 12 March 2026](Published: 12 March 2026)  \nInternational Journ","cbCaitgMq07HZxoG","https://ap.wps.com/l/cbCaitgMq07HZxoG","pdf",13311796,42,"English","# Abstract\n# Introduction\n## Global Epidemiology and Therapeutic Challenges of Hepatocellular Carcinoma\n## Current Treatment Modalities for HCC and Their Challenges","[{\"question\":\"How does nanotechnology improve early diagnosis of hepatocellular carcinoma (HCC)?\",\"answer\":\"It enhances imaging capabilities and leverages tumor-specific biomarkers, enabling more accurate detection at early stages.\"},{\"question\":\"What nanotechnology-enabled therapeutic approaches are discussed for HCC?\",\"answer\":\"The review highlights targeted delivery of chemotherapeutic agents, gene therapies, and immunotherapies, aiming to improve patient outcomes while minimizing side effects.\"},{\"question\":\"What major obstacles are identified for translating nanomedicine to clinical use?\",\"answer\":\"Key challenges include bio-barrier penetration, biocompatibility, and high production costs.\"}]","Nanotechnology-Enabled Diagnosis and Treatment of Hepatocellular Carcinoma - Theranostics, Combination Regimens, and Translation | PDF",1790062396,106,[147,151,155,159,163],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e332bb4254e9112b340c8ffe41676bb.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d0ebff0c9478ac55aee613b6b01c0bc.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2189ca43191db5b6222461b99d4a0509.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4361908b81886b13f0e48a0d1775e26c.webp",980,1268,{"page_no":24,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53cfe1b38ab356a9a1f1841a9d1d0c4e.webp",979,1267]